Genentech ยท 2 hours ago
2026 Summer Intern - Public Affairs & Access: Issue Advocacy & Alliances (US External Affairs)
Washington, DC
Internship
Onsite
Intern
$21/hr - $28/hr
Start in 2026 SpringGenentech is a biotechnology company focused on driving positive change in the healthcare system. The 2026 Summer Intern for Public Affairs & Access will work with the Issue Advocacy & Alliances team to engage stakeholders and support advocacy plans.
BiotechnologyLife ScienceManufacturing
Responsibilities
Attending external stakeholder events including but limited to: patient and provider policy summits, think tank briefings and trade association meetings
Engagement with external stakeholders to understand how key policies impact patients, their organizations and our business
Conduct research on external organization policy positions and support External Affairs team
Projects, events, and other activities as needed
Participate in team strategy sessions as we create advocacy plans on our key priorities
Qualification
Required
Must be pursuing a Bachelor's degree
Must have attained a Bachelor's degree (recent graduates not currently enrolled in a grad program)
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Understanding of the US legislative process
Preferred
Political Science
Economics
Business Administration
Communications
Public Policy
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-16
2026-01-07
Company data provided by crunchbase